Visual field results from a one-year multi-center randomized double-masked study comparing brimonidine tartrate to timolol maleate in the treatment of ocular hypertension and glaucoma

被引：0
|
作者：
Choplin, NT
机构：
[1] USN,MED CTR,DEPT OPHTHALMOL,SAN DIEGO,CA 92152
[2] USN,MED CTR,DEPT CLIN INVEST,SAN DIEGO,CA 92152
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1996年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：2332 / 2332
页数：1
相关论文
共 47 条
  • [1] One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension
    Higginbotham, EJ
    Schuman, JS
    Goldberg, I
    Gross, RL
    VanDenburgh, AM
    Chen, K
    Whitcup, SM
    ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) : 1286 - 1293
  • [2] A Double-Masked Randomized Crossover Study Comparing the Effect of Latanoprost/Timolol and Brimonidine/Timolol Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
    Hommer, Anton
    Sperl, Philipp
    Resch, Hemma
    Popa-Cherecheanu, Alina
    Qiao, Chunyan
    Schmetterer, Leopold
    Garhoefer, Gerhard
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 569 - 575
  • [3] Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol - A double-masked, randomized, one-year study
    Lass, JH
    Eriksson, GL
    Osterling, L
    Simpson, CV
    OPHTHALMOLOGY, 2001, 108 (02) : 264 - 271
  • [4] Comparative safety and ocular hypotensive efficacy of brimonidine tartrate 0.2% and timolol maleate 0.5% in patients with glaucoma or ocular hypertension: 12-month results from an ongoing study
    Lewis, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1149 - 1149
  • [5] TIMOLOL TREATMENT OF CHRONIC OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION - A 2.5-YEAR MULTI-CENTER STUDY
    AIRAKSINEN, PJ
    VALLE, O
    TAKKI, KK
    KLEMETTI, A
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1982, 219 (02) : 68 - 71
  • [6] Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
    Shiro Mizoue
    Koji Nitta
    Motohiro Shirakashi
    Akiyoshi Nitta
    Shigeki Yamabayashi
    Tairo Kimura
    Toshihiko Ueda
    Ryuji Takeda
    Shun Matsumoto
    Keiji Yoshikawa
    Advances in Therapy, 2017, 34 : 1438 - 1448
  • [7] Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
    Mizoue, Shiro
    Nitta, Koji
    Shirakashi, Motohiro
    Nitta, Akiyoshi
    Yamabayashi, Shigeki
    Kimura, Tairo
    Ueda, Toshihiko
    Takeda, Ryuji
    Matsumoto, Shun
    Yoshikawa, Keiji
    ADVANCES IN THERAPY, 2017, 34 (06) : 1438 - 1448
  • [8] A 12-month, multicenter, randomized, double-masked, parallelgroup comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension
    Mundorf, TK
    Ogawa, T
    Naka, H
    Novack, GD
    Crockett, RS
    CLINICAL THERAPEUTICS, 2004, 26 (04) : 541 - 551
  • [9] Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension
    LeBlanc, RP
    OPHTHALMOLOGY, 1998, 105 (10) : 1960 - 1967
  • [10] A six-month, randomized, double masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension
    Watson, P
    Stjernschantz, J
    Beck, L
    Blackmore, M
    Coakes, R
    Reynolds, P
    Davey, C
    HickmanCasey, J
    Elkington, A
    Luff, A
    Green, F
    Valenzuela, F
    Longstaff, S
    Currie, Z
    Mills, B
    Chatterjee, A
    Murray, S
    Nagasubramanian, S
    Potts, M
    Spencer, I
    Roxburgh, S
    Sanders, R
    Bailey, M
    Vernon, S
    Sloper, M
    Wishart, P
    Birch, M
    OPHTHALMOLOGY, 1996, 103 (01) : 126 - 137
12345